Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Muscarinic receptors (M1-M4) are crucial targets for various therapeutic interventions.
• Developing selective muscarinic agonists is essential for targeted drug action and minimizing side effects.
• Heterocyclic compounds like those containing 1,4-dioxane and 1,4-oxathiane moieties are explored for their pharmacological potential.

Purpose of the Study:

• To synthesize novel muscarinic agonists incorporating 1,4-dioxane and 1,4-oxathiane nuclei.
• To evaluate the potency and selectivity of these synthesized compounds across M1-M4 muscarinic receptor subtypes.
• To investigate the influence of stereochemistry on drug-receptor interactions and subtype selectivity.

Main Methods:

• Synthesis of a series of muscarinic agonists featuring 1,4-dioxane and 1,4-oxathiane cores.
• In vitro pharmacological testing to determine agonist potency at M1, M2, M3, and M4 muscarinic receptor subtypes.
• Stereochemical analysis and comparison of cis and trans isomers' activity.

Main Results:

• The stereochemical configuration significantly impacts agonist potency and receptor subtype selectivity.
• Cis isomers demonstrated greater overall potency compared to their corresponding trans isomers.
• Trans isomers exhibited the ability to discriminate between different muscarinic receptor subtypes.
• Compound 5b, a trans isomer, was identified as a highly selective agonist for the ileal M(3) receptor subtype, lacking activity at other subtypes.

Conclusions:

• Stereochemistry is a critical determinant in the design of selective muscarinic agonists.
• The synthesized compounds, particularly trans isomers, offer potential for subtype-specific targeting.
• Compound 5b represents a promising lead compound for developing M(3) receptor-selective therapeutics.